(Q46291767)

21 December 2017

title

Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race (English)

1 reference

21 December 2017

0 references

D A Sclar

1

1 reference

21 December 2017

L M Robison

2

1 reference

21 December 2017

T L Skaer

3

1 reference

21 December 2017

W M Dickson

4

1 reference

21 December 2017

C M Kozma

5

1 reference

21 December 2017

C E Reeder

6

1 reference

21 December 2017

publication date

1 July 1999

1 reference

21 December 2017

The Science of Diabetes Self-Management and Care

published in

1 reference

21 December 2017

volume

25

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

531-2, 535, 537-8

1 reference

21 December 2017

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

21 January 2018

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Evaluating the costs and benefits of outpatient diabetes education and nutrition counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Impact of community-based diabetes education on program attenders and nonattenders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Assessment of sulfonylurea adherence and metabolic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

Compliance becomes concordance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F014572179902500406

10.1177/014572179902500406

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017